Baxter International (BAX)

R&D Expense Growth

-7.19%

Quarterly · Period ending:

BAX logo

BAX R&D Expense Growth

Latest reported-7.19%
BAX Quarterly R&D Growth (QoQ) (0.00% → -7.19%)
High-resolution chart · PNG

BAX r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Baxter International R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-7.1942%
10.3175%
6.7797%
-11.9403%
-4.2857%
-33.6493%
63.5659%
-0.7692%
8.3333%
-30.2326%
29.3233%
-19.3939%
0.6098%
5.8065%
2.649%
2.027%
-1.3333%
8.6957%
6.9767%
-7.1942%
8.5938%
-5.1852%
9.7561%
5.1282%
-19.863%
-6.4103%
8.3333%
-13.253%
28.6822%
-26.2857%
5.4217%
-4.5977%
24.2857%
-23.0769%
21.3333%
-3.2258%
22.0472%
-19.1083%
-1.2579%
-18.4615%
43.3824%
-15.528%
8.7838%
-1.9868%
5.5944%
-57.3134%
124.8322%
-53.7267%
4.2071%
-29.2906%
57.7617%
1.4652%
10.9756%
-15.4639%
0.3448%
-5.2288%
13.7546%
5.9055%
6.2762%
0%
11.6822%
-18.3206%
26.57%
-5.4795%
-3.5242%
-7.7236%
7.8947%
-1.2987%
8.9623%
-6.1947%
-1.7391%
3.6036%
16.8421%
-14.0271%
8.867%
14.6893%
11.3208%
-12.1547%
21.4765%
2.0548%
5.7971%
2.9851%
0.7519%
0%
0%
3.9063%
3.2258%
-3.876%
-5.1471%
-3.5461%
2.9197%
-1.4388%
2.2059%
-3.5461%
15.5738%
-0.813%
6.9565%
0%
9.5238%
0.9615%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.